XOMA Royalty Corporation (FRA:X0M)

Market Cap	347.92M
Revenue (ttm)	40.15M
Net Income	8.40M
EPS	0.70
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	1.84 (8.15%)
Ex-Dividend Date	Apr 2, 2026

Volume	n/a
Average Volume	n/a
Open	22.40
Previous Close	21.54
Day's Range	22.40 - 22.60
52-Week Range	20.40 - 23.60
Beta	n/a
RSI	71.05
Earnings Date	Mar 9, 2026

About XOMA Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X0M